Table 1.

Multivariate analyses of parameters associated with overall survival (OS) and progression free survival (PFS).

Parameter	Value	HRa	HR lower 95CI	HR upper 95CI	P value
OS
Age	≤ 50 versus > 50	0.34	0.04	2.68	0.31
BMI	> 30 versus ≤ 30	1.37	0.72	2.59	0.33
FIGO stage	II versus I	0.55	0.13	2.37	0.42
FIGO stage	III, IV versus I	3.71	1.91	7.21	< .0001*
Tumour grade	2 versus 1	4.14	1.13	15.14	0.03*
Tumour grade	3 versus 1	17.5	4.91	62.43	< .0001*
Subtype	Nonendo versus Endo	0.65	0.3	1.45	0.30
ROR1	High versus low/moderate	2.48	0.99	6.18	0.05*
ROR2	High versus low/moderate	0.77	0.34	1.72	0.52
PFS
Age	≤ 50 versus > 50	0.42	0.1	1.77	0.24
BMI	> 30 versus ≤ 30	0.80	0.48	1.33	0.39
FIGO stage	II versus I	0.91	0.35	2.35	0.85
FIGO stage	III, IV versus I	4.25	2.43	7.43	< .0001*
Tumour Grade	2 versus 1	1.50	0.75	3.02	0.25
Tumour Grade	3 versus 1	5.81	2.83	11.92	< .0001*
ROR1	High versus low/moderate	2.45	1.21	4.97	0.01*
ROR2	High versus low/moderate	0.92	0.51	1.67	0.78

^aHazard ratio.

*Significant at p < 0.05 level.